Burnham's 'Buy British' Drive Targets Palantir's 2 UK Contracts

Prime Minister Andy Burnham has launched a search for a British-made alternative to Palantir Technologies, the U.S. data analytics firm that holds contracts with the National Health Service and the Ministry of Defence, according to the Financial Times. The effort is tied to a broader "buy British" push from Downing Street, the newspaper reported, though the government has not published a timeline, a budget, or a shortlist of domestic candidates.

The FT's reporting is limited to a single dispatch, and several operational details — who within government is running the search, whether existing Palantir contracts would be canceled or simply not renewed, and what a replacement system would need to do — are not yet public. HTT News could not independently verify additional specifics beyond what the Financial Times has reported.

What is Burnham's 'buy British' push actually targeting?

According to the FT, the prime minister's office is examining whether a domestic technology company could take over work currently handled by Palantir inside the health service and the defence establishment. The paper describes Palantir as a "controversial US tech group," without detailing in the portion available to HTT News what specifically has drawn that characterization in this instance. The push appears to be part of a wider policy preference for domestic suppliers on sensitive government work, though the FT item reviewed does not specify whether that preference extends beyond technology procurement to other sectors.

Why has Palantir's UK government role drawn scrutiny?

Palantir has built a presence in British public-sector contracting over several years, and the FT's framing — "controversial" — signals that the company's footprint in health and defence data systems has become a point of political attention under Burnham. The source material reviewed does not lay out the specific objections raised by critics, nor does it include a response from Palantir itself. Readers should treat "controversial" as the Financial Times' characterization rather than an itemized list of grievances, since none appears in the material available for this report.

What contracts does Palantir hold with British agencies?

The Financial Times reports that Palantir has been "awarded health service and defence contracts," language that confirms the company's work spans both the NHS and the Ministry of Defence but does not specify contract values, start dates, or expiration windows. Without those figures in the source record, this report does not estimate them. Any numbers that later surface from government procurement filings or company disclosures would need to be checked against primary documents before being treated as confirmed.

The search for a replacement is, at this stage, a political signal more than a settled procurement decision.

Is there a British company positioned to replace Palantir?

The FT's reporting indicates the hunt for an alternative is underway but does not name a specific UK firm as the leading candidate. That absence matters: Palantir's work inside government, particularly in health data integration, involves specialized software built over years of implementation, and standing up a domestic replacement at comparable scale would likely require time regardless of political appetite. The source material does not address how quickly a transition could occur or whether any British vendor has already been approached.

What happens to existing Palantir contracts while the search continues?

Nothing in the FT item reviewed indicates that current contracts are being suspended, renegotiated, or allowed to lapse immediately. The search for an alternative, as described, appears to be a forward-looking exercise rather than an announcement that Palantir's existing agreements are ending. Procurement decisions inside the NHS and the Ministry of Defence typically involve formal tendering processes, and the FT report does not state that such a process has formally begun.

What to watch

• Whether Downing Street names specific UK companies under consideration as Palantir alternatives.
• Any formal procurement notices from the NHS or Ministry of Defence signaling a tender for replacement systems.
• A public response from Palantir addressing the "buy British" push or defending its current UK contracts.
• Whether the policy extends beyond health and defence into other government technology contracts.
• Confirmation of contract values or timelines that would clarify the scale of any transition.

The Financial Times' original report, which first detailed the search, is available at ft.com. HTT News will update this explainer as government filings, company statements, or further reporting clarify the scope of the effort.